Molecular mechanisms of ERM regulation
ERM调节的分子机制
基本信息
- 批准号:7965921
- 负责人:
- 金额:$ 25.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:ActinsAcuteBindingBiological AssayBiologyCD44 geneCell membraneCellsCellular biologyComplexCytoplasmic TailCytoskeletonCytosolDependenceEventFamilyHydrolysisIn VitroJournalsLipidsLymphocyteLymphocyte ActivationMediatingMediator of activation proteinMembraneModelingMolecularMutationN-terminalPaperPhosphatidylinositol 4,5-DiphosphatePhosphatidylinositolsPhospholipase CPhospholipidsPhosphoric Monoester HydrolasesPhosphorylationProcessProtein DephosphorylationProteinsPublishingRegulationRoleSignal TransductionStromal Cell-Derived Factor 1Transfectionchemokineezrininhibitor/antagonistmoesinmutantprotein protein interactionradixin protein
项目摘要
We first described several years ago the finding that chemokine (SDF-1) stimulation of lymphocytes induces very rapid (onset <=5 sec) ERM dephosphorylation and inactivation. Given the evidence that phosphorylation contributes to ERM activation, it was plausible that dephosphorylation mediated the inactivation. However, membrane phospho-lipid, especially PIP2, is an additional key mediator of ERM activation. We hypothesized that acute reduction of PIP2 could contribute to ERM inactivation. Specifically, we considered the possibility that chemokine: 1) activates phospholipase C (PLC); which 2) mediates reduction of phosphatidylinositol 4,5-bisphosphate (PIP2); which 3) releases ERM from its association with the plasma membrane; and 4) triggers ERM dephosphorylation. This proposed model is supported by multiple findings we have made, including the following. PLC inhibitor blocks these events. Translocation of GFP-tagged moesin into cytosol and ERM dephosphorylation can be induced either by: transfection with active PLC construct; or by acute targeting of phosphoinositide 5-phosphatase to the plasma membrane. PIP2 dependence cannot be replaced by phosphorylation (modeled by T558D mutation) in either of two assays: association with plasma membrane in cells or in vitro association with cytoplasmic tails of proteins like CD44. Moreover, induction of PIP2 hydrolysis is sufficient to induce ERM dephosphorylation, indicating that PLC activation can be sufficient to induce ERM dephosphorylation and that PLC activation may be the initiating event in lymphocytes rather than independent activation of an ERM phosphatase. Key findings made with moesin constructs have been confirmed with ezrin constructs, indicating that these are general principles pertinent to both ezrin and moesin. These results demonstrate a powerful new role of PLCs in rapid cytoskeletal remodeling and an additional key role of PIP2 in ERM biology, namely hydrolysis-mediated ERM inactivation. These studies are described in a paper published this year in Journal of Cell Biology. The complex N-terminal domain of ERM is called the FERM domain which binds to the C-terminus and thereby participates in autoinhibition. In our view, the release of ERM autoinhibition by acidic phospholipid binding is complex and incompletely understood. Therefore, we are conducting additional mutational analysis of FERM domain residues and analyzing the mutant proteins for protein-protein interaction and membrane localization to extend our functional understanding of these key processes.
几年前,我们首先描述了趋化因子(SDF-1)刺激淋巴细胞的刺激会诱导非常快速(发作<= 5 sec)ERM磷酸化和失活。鉴于证据表明磷酸化有助于ERM激活,因此去磷酸化介导了失活是合理的。然而,膜磷酸脂质,尤其是PIP2是ERM活化的另一个关键介体。我们假设PIP2的急性减少可能导致ERM失活。具体而言,我们考虑了趋化因子的可能性:1)激活磷脂酶C(PLC); 2)介导磷脂酰肌醇4,5-双磷酸的还原(PIP2); 3)释放ERM与质膜的关联; 4)触发ERM去磷酸化。我们提出的模型得到了我们已经做出的多个发现的支持,包括以下内容。 PLC抑制剂阻止这些事件。 GFP标记的Moesin转移到细胞质中,ERM去磷酸化可以通过以下方式诱导:用活性PLC构建体转染;或通过将磷酸肌醇5-磷酸酶急性靶向到质膜。 PIP2依赖性不能被两种测定中的任何一个中的任何一个磷酸化(由T558D突变建模)所取代:与细胞中的质膜相关,或与CD44(如CD44)的细胞质尾巴相关。此外,PIP2水解的诱导足以诱导ERM去磷酸化,表明PLC激活足以诱导ERM脱磷酸化,并且PLC激活可能是淋巴细胞中的起始事件,而不是独立的ERM磷酸酶激活。用Ezrin构建体证实了用Moesin构建体制成的主要发现,表明这些是与Ezrin和Moesin有关的一般原则。这些结果表明,PLC在快速细胞骨架重塑中起着强大的新作用,以及PIP2在ERM生物学中的其他关键作用,即水解介导的ERM失活。这些研究在今年发表在细胞生物学杂志上的论文中进行了描述。 ERM的复杂N末端结构域称为FERM结构域,该结构域与C末端结合,从而参与自身抑制。我们认为,通过酸性磷脂结合释放ERM自身抑制作用是复杂且未完全理解的。因此,我们正在对FERM结构域残基进行其他突变分析,并分析突变蛋白的蛋白质 - 蛋白质相互作用和膜定位,以扩展我们对这些关键过程的功能理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James Shaw其他文献
James Shaw的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James Shaw', 18)}}的其他基金
Facilitating Access to Information on Human Proteins and
促进获取有关人类蛋白质和
- 批准号:
7291810 - 财政年份:
- 资助金额:
$ 25.68万 - 项目类别:
Facilitating Access to Information on Human Proteins and Their Phosphorylation
促进获取有关人类蛋白质及其磷酸化的信息
- 批准号:
7965216 - 财政年份:
- 资助金额:
$ 25.68万 - 项目类别:
Facilitating Access to Information on Human Proteins and Their Phosphorylation
促进获取有关人类蛋白质及其磷酸化的信息
- 批准号:
7592641 - 财政年份:
- 资助金额:
$ 25.68万 - 项目类别:
相似国自然基金
新冠病毒N蛋白通过结合RAGE以促进肺泡巨噬细胞内质网-线粒体接触位点(MAM)的形成而诱导急性肺损伤的机制研究
- 批准号:82370080
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Grb2靶向结合MerTK调控巨噬细胞胞葬在急性胰腺炎中的作用及机制研究
- 批准号:82300732
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
支链氨基酸转氨酶1在核心结合因子急性髓细胞白血病中的异常激活与促进白血病发生的分子机制研究
- 批准号:82370178
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
不可逆慢加急性肝衰竭肝再生障碍中低表达核结合因子-β(CBFB)阻碍肝-毛细胆管紧密连接形成及其上游调控机制研究
- 批准号:82370636
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
RNA结合蛋白RCAN1.1靶向调控Miro2促进急性缺血性脑卒中神经元线粒体分裂及分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
microRNA-Regulated Mechanisms Essential for Structural Plasticity of Drosophila Glutamatergic Synapses
microRNA 调控机制对于果蝇谷氨酸突触的结构可塑性至关重要
- 批准号:
10792326 - 财政年份:2023
- 资助金额:
$ 25.68万 - 项目类别:
Chlamydia type III effectors affecting the host actin-based cytoskeleton
III 型衣原体效应子影响宿主肌动蛋白细胞骨架
- 批准号:
10632935 - 财政年份:2023
- 资助金额:
$ 25.68万 - 项目类别:
Rhinovirus, airway smooth muscle, and mechanisms of irreversible airflow obstruction
鼻病毒、气道平滑肌和不可逆气流阻塞机制
- 批准号:
10735460 - 财政年份:2023
- 资助金额:
$ 25.68万 - 项目类别:
Dissecting the Molecular Link Between Stroke, Actin, and Alzheimer's Disease
剖析中风、肌动蛋白和阿尔茨海默病之间的分子联系
- 批准号:
10772704 - 财政年份:2023
- 资助金额:
$ 25.68万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 25.68万 - 项目类别: